Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial
Objective: To determine whether, in acute non-ST elevation coronary syndrome, the benefit from early invasive coronary intervention compared with a conservative strategy of later symptom-guided intervention varies over time. Methods: In RITA 3 (Randomised Intervention Trial of unstable Angina 3) pat...
Gespeichert in:
Veröffentlicht in: | Heart (British Cardiac Society) 2006-10, Vol.92 (10), p.1473-1479 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1479 |
---|---|
container_issue | 10 |
container_start_page | 1473 |
container_title | Heart (British Cardiac Society) |
container_volume | 92 |
creator | Poole-Wilson, P A Pocock, S J Fox, K A A Henderson, R A Wheatley, D J Chamberlain, D A Shaw, T R D Clayton, T C |
description | Objective: To determine whether, in acute non-ST elevation coronary syndrome, the benefit from early invasive coronary intervention compared with a conservative strategy of later symptom-guided intervention varies over time. Methods: In RITA 3 (Randomised Intervention Trial of unstable Angina 3) patients were randomly assigned to coronary angiography (median 2 days after randomisation) and appropriate intervention (n = 895) or to a symptom-guided conservative strategy (n = 915). Results: In the first week patients in both groups were at highest risk of death, myocardial infarction (MI) or refractory angina (incidence rate 40 times higher than in months 5–12 of follow up). There were 22 MIs and 6 deaths in the intervention group (largely due to procedure-related events, 14 MIs and 3 deaths) versus 17 MIs and 3 deaths in the conservative group. In the rest of the year there were an additional 12 versus 27 MIs, respectively (treatment–time interaction p = 0.021). Over one year in the intervention group there was a 43% reduction in refractory angina; 22% of patients underwent coronary artery bypass surgery and 35% underwent percutaneous coronary intervention only, which reduced refractory angina but provoked some early MIs; and 43% were still treated medically, mostly because of a favourable initial angiogram. Conclusion: Any intervention policy needs to recognise the high risk of events in the first week and the substantial minority of patients not needing intervention. Intervention may be best targeted at higher risk patients, as the early hazards of the procedure are then offset by reduced subsequent events. |
doi_str_mv | 10.1136/hrt.2005.060541 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1861054</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68861951</sourcerecordid><originalsourceid>FETCH-LOGICAL-b522t-7c82818bdb4c63ec30762b0e11d48d566c269fe6aafce8f79ad1b77aa8399dba3</originalsourceid><addsrcrecordid>eNqFkk2P0zAQhiMEYpeFMzdkCcEBKV07aRxnD0irio9KC0hLQb1ZE2eyTUnsYrsV_Vf8RCa02gUunGzNPPP6Hc8kyVPBJ0Lk8nzl4yTjvJhwyYupuJeciqlUacbF8j7d86JIJc_Lk-RRCGvO-bRS8mFyIqTMhFLZafJzbiP6HdrYOQs926EP28CMs4HCELsdsugR4kAI6ywDs43IrLPp5wXDHkfGWSrwVO_3LOxt492AFyx2A1J86wMy17INgaPGABZu8Lcc2IY1XUAgAkcPgTkywJxFtkfw43txhex6vrhkOfnooH-cPGihD_jkeJ4lX96-Wczep1ef3s1nl1dpXWRZTEujMiVU3dRTI3M0OS9lVnMUopmqppDSZLJqUQK0BlVbVtCIuiwBVF5VTQ35WfL6oLvZ1gM2htx56PXGdwO1qR10-u-M7Vb6xu20UFLQLEjg5VHAu-9bDFEPXTDY92DRbYOWisCqEAQ-_wdc06fRMIIWpeKy4rkaqfMDZbwLwWN7a0VwPe6Cpl3Q4y7owy5QxbM_O7jjj8Mn4MURgGCgbz1Y04U7Tomi4LIkLj1wXYj44zYP_pumbFnoj19nelnlH5alEvqa-FcHvh7W_3X5C4FF3iA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1780690381</pqid></control><display><type>article</type><title>Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial</title><source>MEDLINE</source><source>BMJ Journals - NESLi2</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Poole-Wilson, P A ; Pocock, S J ; Fox, K A A ; Henderson, R A ; Wheatley, D J ; Chamberlain, D A ; Shaw, T R D ; Clayton, T C</creator><creatorcontrib>Poole-Wilson, P A ; Pocock, S J ; Fox, K A A ; Henderson, R A ; Wheatley, D J ; Chamberlain, D A ; Shaw, T R D ; Clayton, T C ; Randomised Intervention Trial of unstable Angina Investigators</creatorcontrib><description>Objective: To determine whether, in acute non-ST elevation coronary syndrome, the benefit from early invasive coronary intervention compared with a conservative strategy of later symptom-guided intervention varies over time. Methods: In RITA 3 (Randomised Intervention Trial of unstable Angina 3) patients were randomly assigned to coronary angiography (median 2 days after randomisation) and appropriate intervention (n = 895) or to a symptom-guided conservative strategy (n = 915). Results: In the first week patients in both groups were at highest risk of death, myocardial infarction (MI) or refractory angina (incidence rate 40 times higher than in months 5–12 of follow up). There were 22 MIs and 6 deaths in the intervention group (largely due to procedure-related events, 14 MIs and 3 deaths) versus 17 MIs and 3 deaths in the conservative group. In the rest of the year there were an additional 12 versus 27 MIs, respectively (treatment–time interaction p = 0.021). Over one year in the intervention group there was a 43% reduction in refractory angina; 22% of patients underwent coronary artery bypass surgery and 35% underwent percutaneous coronary intervention only, which reduced refractory angina but provoked some early MIs; and 43% were still treated medically, mostly because of a favourable initial angiogram. Conclusion: Any intervention policy needs to recognise the high risk of events in the first week and the substantial minority of patients not needing intervention. Intervention may be best targeted at higher risk patients, as the early hazards of the procedure are then offset by reduced subsequent events.</description><identifier>ISSN: 1355-6037</identifier><identifier>EISSN: 1468-201X</identifier><identifier>DOI: 10.1136/hrt.2005.060541</identifier><identifier>PMID: 16621882</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Cardiovascular Society</publisher><subject>acute coronary syndrome ; Adult ; Aged ; Angina pectoris ; Angina, Unstable - mortality ; Angina, Unstable - therapy ; Biological and medical sciences ; CABG ; Cardiology. Vascular system ; Cardiovascular disease ; Confidence intervals ; coronary angiography ; Coronary Artery Bypass ; coronary artery bypass graft ; Coronary heart disease ; Coronary vessels ; Female ; Fragmin and Fast Revascularisation during Instability in Coronary artery disease ; FRISC II ; Heart ; Heart attacks ; Humans ; ICTUS ; Interventional Cardiology and Surgery ; Invasive versus Conservative Treatment in Unstable Coronary Syndromes ; Male ; Medical imaging ; Medical sciences ; Middle Aged ; Mortality ; myocardial infarction ; Myocardial Infarction - etiology ; Myocardial Infarction - mortality ; myocardial ischaemia ; PCI ; percutaneous coronary intervention ; Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors ; Randomised Intervention Trial of unstable Angina 3 ; Recurrence ; Risk Factors ; RITA 3 ; Survival Analysis ; TACTICS ; Treat angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy ; Treatment Outcome ; VANQWISH ; Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital</subject><ispartof>Heart (British Cardiac Society), 2006-10, Vol.92 (10), p.1473-1479</ispartof><rights>Copyright 2006 by Heart</rights><rights>2006 INIST-CNRS</rights><rights>Copyright: 2006 Copyright 2006 by Heart</rights><rights>Copyright © 2006 BMJ Publishing Group and British Cardiovascular Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b522t-7c82818bdb4c63ec30762b0e11d48d566c269fe6aafce8f79ad1b77aa8399dba3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://heart.bmj.com/content/92/10/1473.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://heart.bmj.com/content/92/10/1473.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,230,314,725,778,782,883,3185,23554,27907,27908,53774,53776,77351,77382</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18155067$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16621882$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Poole-Wilson, P A</creatorcontrib><creatorcontrib>Pocock, S J</creatorcontrib><creatorcontrib>Fox, K A A</creatorcontrib><creatorcontrib>Henderson, R A</creatorcontrib><creatorcontrib>Wheatley, D J</creatorcontrib><creatorcontrib>Chamberlain, D A</creatorcontrib><creatorcontrib>Shaw, T R D</creatorcontrib><creatorcontrib>Clayton, T C</creatorcontrib><creatorcontrib>Randomised Intervention Trial of unstable Angina Investigators</creatorcontrib><title>Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial</title><title>Heart (British Cardiac Society)</title><addtitle>Heart</addtitle><description>Objective: To determine whether, in acute non-ST elevation coronary syndrome, the benefit from early invasive coronary intervention compared with a conservative strategy of later symptom-guided intervention varies over time. Methods: In RITA 3 (Randomised Intervention Trial of unstable Angina 3) patients were randomly assigned to coronary angiography (median 2 days after randomisation) and appropriate intervention (n = 895) or to a symptom-guided conservative strategy (n = 915). Results: In the first week patients in both groups were at highest risk of death, myocardial infarction (MI) or refractory angina (incidence rate 40 times higher than in months 5–12 of follow up). There were 22 MIs and 6 deaths in the intervention group (largely due to procedure-related events, 14 MIs and 3 deaths) versus 17 MIs and 3 deaths in the conservative group. In the rest of the year there were an additional 12 versus 27 MIs, respectively (treatment–time interaction p = 0.021). Over one year in the intervention group there was a 43% reduction in refractory angina; 22% of patients underwent coronary artery bypass surgery and 35% underwent percutaneous coronary intervention only, which reduced refractory angina but provoked some early MIs; and 43% were still treated medically, mostly because of a favourable initial angiogram. Conclusion: Any intervention policy needs to recognise the high risk of events in the first week and the substantial minority of patients not needing intervention. Intervention may be best targeted at higher risk patients, as the early hazards of the procedure are then offset by reduced subsequent events.</description><subject>acute coronary syndrome</subject><subject>Adult</subject><subject>Aged</subject><subject>Angina pectoris</subject><subject>Angina, Unstable - mortality</subject><subject>Angina, Unstable - therapy</subject><subject>Biological and medical sciences</subject><subject>CABG</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular disease</subject><subject>Confidence intervals</subject><subject>coronary angiography</subject><subject>Coronary Artery Bypass</subject><subject>coronary artery bypass graft</subject><subject>Coronary heart disease</subject><subject>Coronary vessels</subject><subject>Female</subject><subject>Fragmin and Fast Revascularisation during Instability in Coronary artery disease</subject><subject>FRISC II</subject><subject>Heart</subject><subject>Heart attacks</subject><subject>Humans</subject><subject>ICTUS</subject><subject>Interventional Cardiology and Surgery</subject><subject>Invasive versus Conservative Treatment in Unstable Coronary Syndromes</subject><subject>Male</subject><subject>Medical imaging</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>myocardial infarction</subject><subject>Myocardial Infarction - etiology</subject><subject>Myocardial Infarction - mortality</subject><subject>myocardial ischaemia</subject><subject>PCI</subject><subject>percutaneous coronary intervention</subject><subject>Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors</subject><subject>Randomised Intervention Trial of unstable Angina 3</subject><subject>Recurrence</subject><subject>Risk Factors</subject><subject>RITA 3</subject><subject>Survival Analysis</subject><subject>TACTICS</subject><subject>Treat angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy</subject><subject>Treatment Outcome</subject><subject>VANQWISH</subject><subject>Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital</subject><issn>1355-6037</issn><issn>1468-201X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkk2P0zAQhiMEYpeFMzdkCcEBKV07aRxnD0irio9KC0hLQb1ZE2eyTUnsYrsV_Vf8RCa02gUunGzNPPP6Hc8kyVPBJ0Lk8nzl4yTjvJhwyYupuJeciqlUacbF8j7d86JIJc_Lk-RRCGvO-bRS8mFyIqTMhFLZafJzbiP6HdrYOQs926EP28CMs4HCELsdsugR4kAI6ywDs43IrLPp5wXDHkfGWSrwVO_3LOxt492AFyx2A1J86wMy17INgaPGABZu8Lcc2IY1XUAgAkcPgTkywJxFtkfw43txhex6vrhkOfnooH-cPGihD_jkeJ4lX96-Wczep1ef3s1nl1dpXWRZTEujMiVU3dRTI3M0OS9lVnMUopmqppDSZLJqUQK0BlVbVtCIuiwBVF5VTQ35WfL6oLvZ1gM2htx56PXGdwO1qR10-u-M7Vb6xu20UFLQLEjg5VHAu-9bDFEPXTDY92DRbYOWisCqEAQ-_wdc06fRMIIWpeKy4rkaqfMDZbwLwWN7a0VwPe6Cpl3Q4y7owy5QxbM_O7jjj8Mn4MURgGCgbz1Y04U7Tomi4LIkLj1wXYj44zYP_pumbFnoj19nelnlH5alEvqa-FcHvh7W_3X5C4FF3iA</recordid><startdate>20061001</startdate><enddate>20061001</enddate><creator>Poole-Wilson, P A</creator><creator>Pocock, S J</creator><creator>Fox, K A A</creator><creator>Henderson, R A</creator><creator>Wheatley, D J</creator><creator>Chamberlain, D A</creator><creator>Shaw, T R D</creator><creator>Clayton, T C</creator><general>BMJ Publishing Group Ltd and British Cardiovascular Society</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><general>BMJ Group</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20061001</creationdate><title>Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial</title><author>Poole-Wilson, P A ; Pocock, S J ; Fox, K A A ; Henderson, R A ; Wheatley, D J ; Chamberlain, D A ; Shaw, T R D ; Clayton, T C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b522t-7c82818bdb4c63ec30762b0e11d48d566c269fe6aafce8f79ad1b77aa8399dba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>acute coronary syndrome</topic><topic>Adult</topic><topic>Aged</topic><topic>Angina pectoris</topic><topic>Angina, Unstable - mortality</topic><topic>Angina, Unstable - therapy</topic><topic>Biological and medical sciences</topic><topic>CABG</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular disease</topic><topic>Confidence intervals</topic><topic>coronary angiography</topic><topic>Coronary Artery Bypass</topic><topic>coronary artery bypass graft</topic><topic>Coronary heart disease</topic><topic>Coronary vessels</topic><topic>Female</topic><topic>Fragmin and Fast Revascularisation during Instability in Coronary artery disease</topic><topic>FRISC II</topic><topic>Heart</topic><topic>Heart attacks</topic><topic>Humans</topic><topic>ICTUS</topic><topic>Interventional Cardiology and Surgery</topic><topic>Invasive versus Conservative Treatment in Unstable Coronary Syndromes</topic><topic>Male</topic><topic>Medical imaging</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>myocardial infarction</topic><topic>Myocardial Infarction - etiology</topic><topic>Myocardial Infarction - mortality</topic><topic>myocardial ischaemia</topic><topic>PCI</topic><topic>percutaneous coronary intervention</topic><topic>Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors</topic><topic>Randomised Intervention Trial of unstable Angina 3</topic><topic>Recurrence</topic><topic>Risk Factors</topic><topic>RITA 3</topic><topic>Survival Analysis</topic><topic>TACTICS</topic><topic>Treat angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy</topic><topic>Treatment Outcome</topic><topic>VANQWISH</topic><topic>Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Poole-Wilson, P A</creatorcontrib><creatorcontrib>Pocock, S J</creatorcontrib><creatorcontrib>Fox, K A A</creatorcontrib><creatorcontrib>Henderson, R A</creatorcontrib><creatorcontrib>Wheatley, D J</creatorcontrib><creatorcontrib>Chamberlain, D A</creatorcontrib><creatorcontrib>Shaw, T R D</creatorcontrib><creatorcontrib>Clayton, T C</creatorcontrib><creatorcontrib>Randomised Intervention Trial of unstable Angina Investigators</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Heart (British Cardiac Society)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Poole-Wilson, P A</au><au>Pocock, S J</au><au>Fox, K A A</au><au>Henderson, R A</au><au>Wheatley, D J</au><au>Chamberlain, D A</au><au>Shaw, T R D</au><au>Clayton, T C</au><aucorp>Randomised Intervention Trial of unstable Angina Investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial</atitle><jtitle>Heart (British Cardiac Society)</jtitle><addtitle>Heart</addtitle><date>2006-10-01</date><risdate>2006</risdate><volume>92</volume><issue>10</issue><spage>1473</spage><epage>1479</epage><pages>1473-1479</pages><issn>1355-6037</issn><eissn>1468-201X</eissn><abstract>Objective: To determine whether, in acute non-ST elevation coronary syndrome, the benefit from early invasive coronary intervention compared with a conservative strategy of later symptom-guided intervention varies over time. Methods: In RITA 3 (Randomised Intervention Trial of unstable Angina 3) patients were randomly assigned to coronary angiography (median 2 days after randomisation) and appropriate intervention (n = 895) or to a symptom-guided conservative strategy (n = 915). Results: In the first week patients in both groups were at highest risk of death, myocardial infarction (MI) or refractory angina (incidence rate 40 times higher than in months 5–12 of follow up). There were 22 MIs and 6 deaths in the intervention group (largely due to procedure-related events, 14 MIs and 3 deaths) versus 17 MIs and 3 deaths in the conservative group. In the rest of the year there were an additional 12 versus 27 MIs, respectively (treatment–time interaction p = 0.021). Over one year in the intervention group there was a 43% reduction in refractory angina; 22% of patients underwent coronary artery bypass surgery and 35% underwent percutaneous coronary intervention only, which reduced refractory angina but provoked some early MIs; and 43% were still treated medically, mostly because of a favourable initial angiogram. Conclusion: Any intervention policy needs to recognise the high risk of events in the first week and the substantial minority of patients not needing intervention. Intervention may be best targeted at higher risk patients, as the early hazards of the procedure are then offset by reduced subsequent events.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Cardiovascular Society</pub><pmid>16621882</pmid><doi>10.1136/hrt.2005.060541</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1355-6037 |
ispartof | Heart (British Cardiac Society), 2006-10, Vol.92 (10), p.1473-1479 |
issn | 1355-6037 1468-201X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1861054 |
source | MEDLINE; BMJ Journals - NESLi2; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | acute coronary syndrome Adult Aged Angina pectoris Angina, Unstable - mortality Angina, Unstable - therapy Biological and medical sciences CABG Cardiology. Vascular system Cardiovascular disease Confidence intervals coronary angiography Coronary Artery Bypass coronary artery bypass graft Coronary heart disease Coronary vessels Female Fragmin and Fast Revascularisation during Instability in Coronary artery disease FRISC II Heart Heart attacks Humans ICTUS Interventional Cardiology and Surgery Invasive versus Conservative Treatment in Unstable Coronary Syndromes Male Medical imaging Medical sciences Middle Aged Mortality myocardial infarction Myocardial Infarction - etiology Myocardial Infarction - mortality myocardial ischaemia PCI percutaneous coronary intervention Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors Randomised Intervention Trial of unstable Angina 3 Recurrence Risk Factors RITA 3 Survival Analysis TACTICS Treat angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy Treatment Outcome VANQWISH Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital |
title | Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T09%3A18%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interventional%20versus%20conservative%20treatment%20in%20acute%20non-ST%20elevation%20coronary%20syndrome:%20time%20course%20of%20patient%20management%20and%20disease%20events%20over%20one%20year%20in%20the%20RITA%203%20trial&rft.jtitle=Heart%20(British%20Cardiac%20Society)&rft.au=Poole-Wilson,%20P%20A&rft.aucorp=Randomised%20Intervention%20Trial%20of%20unstable%20Angina%20Investigators&rft.date=2006-10-01&rft.volume=92&rft.issue=10&rft.spage=1473&rft.epage=1479&rft.pages=1473-1479&rft.issn=1355-6037&rft.eissn=1468-201X&rft_id=info:doi/10.1136/hrt.2005.060541&rft_dat=%3Cproquest_pubme%3E68861951%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1780690381&rft_id=info:pmid/16621882&rfr_iscdi=true |